SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000182
Filing Date
2016-08-04
Accepted
2016-08-04 16:05:27
Documents
3
Period of Report
2016-08-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201608048xkdocdividend.htm 8-K 25656
2 PRESS RELEASE pdli-201608048xkex991divid.htm EX-99.1 14640
3 pdl-logoa04a01a01a01a02a18.jpg GRAPHIC 59351
  Complete submission text file 0000882104-16-000182.txt   123233
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 161807381
SIC: 2836 Biological Products, (No Diagnostic Substances)